Skip to content

上市筹备 · 2026-01-27

Subsequent Events Impact on Pre-IPO Financial Statements: What to Disclose

The SFC and HKEX’s joint statement in December 2024 on sponsor due diligence for material subsequent events has recalibrated the disclosure threshold for pre-IPO financial statements. The statement explicitly warned that failure to identify and disclose post-balance-sheet events that render previously filed financial information misleading could result in enforcement action under the Securities and Futures Ordinance (Cap. 571) and the Listing Rules. This came after the HKEX’s Listing Committee noted in its 2024 annual review that 23% of IPO rejection cases in 2023 involved inadequate or delayed disclosure of subsequent events, with the majority pertaining to revenue recognition changes, asset impairments, or material litigation arising between the balance sheet date and the listing date. For CFOs and company secretaries of issuers targeting a Main Board or GEM listing in 2025-2026, this means the traditional cutoff date for financial statement liability—the date the auditor signs the report—is no longer the operative boundary. The regulatory expectation now extends to the prospectus registration date, and in some cases, to the first day of trading. This article dissects the three categories of subsequent events under HKFRS, maps them onto the HKEX disclosure framework, and provides a practical checklist for sponsors and reporting accountants to avoid the most common pitfalls.

The Regulatory Framework: Where Subsequent Events Meet Listing Rules

HKFRS vs. Listing Rules: Two Overlapping Timelines

Under HKFRS 10 Events After the Reporting Period, subsequent events fall into two categories: adjusting events (Type 1) and non-adjusting events (Type 2). Type 1 events provide evidence of conditions that existed at the balance sheet date and require adjustment to the financial statements. Type 2 events are indicative of conditions that arose after the balance sheet date and require disclosure but not adjustment.

The HKEX Listing Rules, however, impose a third category: events that, while technically non-adjusting under HKFRS, are nonetheless material enough to require disclosure in the prospectus under Rule 11.10 of the Main Board Listing Rules and Rule 7.09 of the GEM Listing Rules. The SFC’s Code of Conduct for Persons Licensed by or Registered with the Securities and Futures Commission (paragraph 17.6) further requires sponsors to conduct “reasonable due diligence” to identify any subsequent event that could affect an investor’s decision, up to the date the prospectus is issued.

The practical tension arises because the HKFRS cutoff is the date the financial statements are authorised for issue—typically the date the auditor’s report is signed. The Listing Rules cutoff is the prospectus registration date, which can be 6 to 12 months later. A 2023 study by the Hong Kong Institute of Certified Public Accountants (HKICPA) found that 67% of IPO prospectuses filed in 2022-2023 contained at least one disclosure of a non-adjusting subsequent event that occurred between the audit report date and the prospectus registration date.

The 2024 Joint Statement: A Shift in Enforcement Focus

The SFC and HKEX’s December 2024 joint statement on sponsor due diligence explicitly addressed this gap. The statement cited three enforcement cases from 2022-2024 where sponsors failed to identify subsequent events that materially misrepresented the issuer’s financial position:

  • In one case, an issuer in the consumer goods sector recognised a significant impairment on trade receivables two months after the balance sheet date, but the sponsor did not adjust the financial statements or disclose the event in the prospectus.
  • In another, a technology company entered into a material litigation settlement three weeks after the auditor’s report date, which reduced net profit by 18%. The sponsor only disclosed this in response to an HKEX enquiry during the vetting process.
  • The third case involved a property developer that lost a major government tender after the balance sheet date, directly impacting the valuation of its development properties. The sponsor classified this as a non-adjusting event and disclosed it in a footnote, but the SFC argued it should have been treated as an adjusting event because the tender outcome reflected conditions that existed at the balance sheet date.

The SFC’s position in all three cases was that the sponsor had failed to meet the “reasonable due diligence” standard under paragraph 17.6 of the Code of Conduct. The HKEX imposed a public censure on one sponsor and a fine of HKD 15 million on another.

Categorising Subsequent Events for Pre-IPO Disclosure

Type 1: Adjusting Events — When the Past Dictates the Present

Adjusting events under HKFRS 10 require the issuer to amend the financial statements if the event provides additional evidence of conditions that existed at the balance sheet date. Common examples in the pre-IPO context include:

  • Bankruptcy of a major customer occurring within 12 months of the balance sheet date, if the customer’s financial deterioration existed at year-end.
  • Settlement of a legal claim where the underlying cause of action arose before the balance sheet date, even if the settlement amount is finalised after.
  • Asset impairment triggers that existed at year-end but were only quantified after the reporting period—for example, a decline in property valuations confirmed by an independent valuer’s report issued post-year-end.

For issuers targeting a Main Board listing, the reporting accountant must ensure that the financial statements reflect these adjustments up to the date the auditor’s report is signed. However, if a Type 1 event occurs between the audit report date and the prospectus registration date, the issuer must restate the financial statements and obtain a new auditor’s report, or at minimum, disclose the adjustment in the prospectus with the auditor’s consent.

Data from the HKEX’s 2024 annual report on IPO vetting shows that 14% of prospectus amendments requested by the Listing Department in 2023 related to Type 1 events that were initially classified as Type 2 by the sponsor.

Type 2: Non-Adjusting Events — Disclosure, Not Adjustment

Non-adjusting events require disclosure but no change to the financial statements. The HKFRS 10 standard requires disclosure of the nature of the event and an estimate of its financial effect, or a statement that such an estimate cannot be made.

For pre-IPO issuers, the most common Type 2 events include:

  • Material acquisitions or disposals after the balance sheet date, where the transaction does not relate to assets or liabilities existing at year-end.
  • Changes in foreign exchange rates that significantly impact the issuer’s net assets or earnings, particularly relevant for issuers with substantial PRC operations reporting in RMB.
  • Natural disasters or geopolitical events that disrupt operations but did not exist as conditions at the balance sheet date.

The HKEX Listing Rules impose a stricter disclosure threshold than HKFRS for Type 2 events. Under Main Board Rule 11.10, any event that “would have a material effect on the information contained in the listing document” must be disclosed, regardless of whether it meets the HKFRS definition of a non-adjusting event. The HKEX’s Guidance Letter GL57-13 (updated in 2024) clarifies that this includes events that could affect an investor’s assessment of the issuer’s financial position, business prospects, or the adequacy of working capital.

The Grey Zone: Events That Could Be Either

The most contentious area in pre-IPO financial statement preparation is the classification of events that fall into a grey zone between Type 1 and Type 2. The SFC’s enforcement actions in 2023-2024 indicate a clear preference for treating ambiguous events as Type 1 unless the sponsor can demonstrate, with documentary evidence, that the condition did not exist at the balance sheet date.

Common grey-zone examples include:

  • Loss of a major contract after the balance sheet date, where the issuer claims the contract was still in force at year-end but the counterparty had already indicated non-renewal. The SFC’s position is that if the counterparty’s intention existed at year-end, the loss is a Type 1 event.
  • A change in government regulation announced after the balance sheet date but where the legislative process was underway before year-end. In a 2023 enforcement case involving a pharmaceutical issuer, the SFC argued that the proposed regulation was a “known condition” at year-end and required an impairment adjustment.
  • A material decline in the issuer’s share price in the secondary market after the balance sheet date, if the decline is linked to a condition that existed at year-end—for example, a product recall that was under investigation before year-end but only publicly announced after.

The HKEX’s Listing Committee, in its 2024 annual report, noted that 31% of subsequent-event-related enquiries during IPO vetting in 2023 involved events that the sponsor classified as Type 2 but the HKEX reclassified as Type 1.

Practical Disclosure Mechanics for CFOs and Company Secretaries

The Prospectus Disclosure Checklist

For issuers preparing an A1 filing, the subsequent events disclosure must cover three distinct periods:

  1. From balance sheet date to auditor’s report date: The financial statements must reflect all Type 1 adjustments. The reporting accountant must confirm in the audit report that no additional Type 1 events have been identified.
  2. From auditor’s report date to prospectus registration date: The issuer must prepare a “subsequent events memorandum” covering all events in this period. The sponsor must review this memorandum and confirm that all material events—both Type 1 and Type 2—are appropriately disclosed in the prospectus.
  3. From prospectus registration date to the first day of trading: The sponsor must maintain a “post-registration monitoring process” to identify any events that could render the prospectus misleading. Under the SFC’s Code of Conduct paragraph 17.6(d), the sponsor must notify the HKEX immediately if any such event occurs.

The HKEX’s Guidance Letter GL57-13 (2024 update) provides a non-exhaustive list of events that must be considered for disclosure:

  • Changes in the issuer’s financial position, including material borrowings, guarantees, or contingent liabilities.
  • Changes in the issuer’s business operations, including entry into or termination of material contracts.
  • Changes in the issuer’s management or ownership structure.
  • Changes in the regulatory or legal environment affecting the issuer’s business.
  • Any event that could affect the issuer’s ability to meet the listing conditions under Main Board Rule 8.05 or GEM Rule 11.12A.

The Sponsor’s Due Diligence Obligations

The SFC’s December 2024 joint statement introduced specific requirements for sponsor due diligence on subsequent events:

  • Timeline of due diligence: The sponsor must conduct a subsequent events review at least twice during the IPO process—once at the date of the auditor’s report and once at the date of the prospectus registration. For issuers with a long gap between these dates (more than 6 months), the SFC recommends quarterly reviews.
  • Documentation requirements: The sponsor must maintain a written record of all subsequent events identified, the analysis supporting their classification as Type 1 or Type 2, and the rationale for any decision not to adjust or disclose. The SFC’s enforcement division has indicated that it will request these records in any post-IPO inspection.
  • Management representations: The sponsor must obtain a written representation from the issuer’s management, signed by the CFO and company secretary, confirming that all subsequent events have been disclosed to the sponsor. This representation must be updated at the prospectus registration date.

Working Capital Confirmation and Subsequent Events

One area where subsequent events have a direct impact on listing eligibility is the working capital confirmation. Under Main Board Rule 11.17 and GEM Rule 11.27, the issuer must confirm that it has sufficient working capital for at least 12 months from the date of the prospectus.

A subsequent event that reduces working capital—for example, a material capital expenditure commitment entered into after the balance sheet date—can render the working capital confirmation inaccurate. In a 2023 enforcement case, the HKEX required an issuer to postpone its listing by three months because a post-balance-sheet acquisition reduced its working capital below the minimum threshold.

The reporting accountant must include the working capital confirmation in the prospectus, and the sponsor must ensure that the confirmation takes into account all subsequent events up to the prospectus registration date. The HKEX’s 2024 annual report noted that 8% of IPO applications submitted in 2023 required a revised working capital confirmation due to subsequent events.

Actionable Takeaways for Pre-IPO Issuers

  1. Establish a formal subsequent events monitoring process that runs from the balance sheet date through the first day of trading, with designated responsibility assigned to the company secretary and CFO, and documented in the issuer’s internal control procedures.

  2. Require the sponsor to conduct at least two formal subsequent events reviews — one at the auditor’s report date and one at the prospectus registration date — and maintain a written record of all events identified and the classification analysis.

  3. Obtain a management representation letter signed by the CFO and company secretary at the prospectus registration date, confirming that all subsequent events have been disclosed to the sponsor and the reporting accountant.

  4. Treat any event that could be classified as either Type 1 or Type 2 as Type 1 unless the sponsor can provide a documented analysis demonstrating, with supporting evidence, that the condition did not exist at the balance sheet date.

  5. Update the working capital confirmation to reflect all subsequent events up to the prospectus registration date, and ensure the confirmation covers at least 12 months from the date of the prospectus, not from the balance sheet date.